Key result
Patients with type 4 CRS had lower serum SOD levels than controls, while apocynin improved LVEF in subtotal nephrectomy rats.
Why the study?
The relationship between oxidative stress and cardiac injury in type 4 cardiorenal syndrome (CRS), and whether the antioxidant apocynin attenuates this cardiac injury and by what mechanisms, needed to be determined.
Cross-Sectional (n=33)
No
Answers are grounded in this paper and cite their sources.
Supports oxidative stress investigation in type 4 CRS; does not yet justify clinical management changes.
BACKGROUND: Type 4 cardiorenal syndrome (CRS) refers to the cardiac injury induced by chronic kidney disease. We aimed to assess oxidative stress and cardiac injury in patients with type 4 CRS, determine whether the antioxidant apocynin attenuated cardiac injury in rats with type 4 CRS, and explore potential mechanisms. METHODS AND RESULTS: A cross-sectional study was conducted among patients with type 4 CRS (n=17) and controls (n=16). Compared with controls, patients with type 4 CRS showed elevated oxidative stress, which was significantly correlated with cardiac hypertrophy and decreased ejection fraction. In vivo study, male Sprague-Dawley rats underwent 5/6 subtotal nephrectomy and sham surgery, followed with apocynin or vehicle treatment for 8 weeks. Eight weeks after surgery, the 5/6 subtotal nephrectomy rats mimicked type 4 CRS, showing increased serum creatinine, cardiac hypertrophy and fibrosis, and decreased ejection fraction compared with sham-operated animals. Cardiac malondialdehyde, NADPH oxidase activity, fibroblast growth factor-2, and extracellular signal-regulated kinase 1/2 (ERK1/2) phosphorylation increased significantly in the 5/6 subtotal nephrectomy rats. These changes were significantly attenuated by apocynin. In vitro study showed that apocynin reduced angiotensin II-induced NADPH oxidase-dependent oxidative stress, upregulation of fibroblast growth factor-2 and fibrosis biomarkers, and ERK1/2 phosphorylation in cardiac fibroblasts. Importantly, the ERK1/2 inhibitor U0126 reduced the upregulation of fibroblast growth factor-2 and fibrosis biomarkers in angiotensin II-treated fibroblasts. CONCLUSIONS: Oxidative stress is a candidate mediator for type 4 CRS. Apocynin attenuated cardiac injury in type 4 CRS rats via inhibiting NADPH oxidase-dependent oxidative stress-activated ERK1/2 pathway and subsequent fibroblast growth factor-2 upregulation. Our study added evidence to the beneficial effect of apocynin in type 4 CRS.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2015) conducted a cross-sectional in Type 4 cardiorenal syndrome (n=33). Type 4 cardiorenal syndrome (human study) / Apocynin (rat model) vs. Hypertensive controls without renal abnormalities or heart failure was evaluated on Serum superoxide dismutase (SOD) level (U/mL) (p=<0.05). Patients with type 4 CRS had lower serum SOD levels than controls, while apocynin improved LVEF in subtotal nephrectomy rats.
Synapse has enriched 10 related papers. Consider them for comparative context: